Using AI to Predict Ulcerative Colitis Flares in Patients in Remission
Tests an AI model predicting new ulcerative colitis flares in adults already in remission.
Plain-language title generated from the registry record
Registry title: Personalised Prediction of Disease Course in Ulcerative Colitis Using Multimodal Machine Learning - Part of the Presager Project
Key facts
- Where
- Hvidovre, DenmarkSee the site
Where in Denmark
- Gastrounit, medical section, Copenhagen University Hospital HvidovreHvidovre, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Copenhagen University Hospital, Hvidovre
- Trial code
- NCT05479617
- Record updated
- 27 February 2025
- Original description
In patients achieving clinical remission following a flare, artificial intelligence can reliably predict a new flare within the next 12 months utilizing clinical and objective information at day 0 and week 8.Read full original descriptionShow less
Personalised Prediction of Disease Course in Ulcerative Colitis Using Multimodal Machine Learning - Part of the Presager Project
In patients achieving clinical remission following a flare, artificial intelligence can reliably predict a new flare within the next 12 months utilizing clinical and objective information at day 0 and week 8.
Secondary endpoints:
* An artificial intelligence model's precision in predicting a new flare within 2 and 3 years * An artificial intelligence model's precision to rule out patients who will not experience a new flare within 1, 2 and 3 year
Inclusion: Signed informed consent; Diagnosis of UC for at least 1 year; Relapse due to UC; First endoscopic and histological evaluation of the flare Exclusion criteria; Well-founded doubt that the flare is due to other than the patients UC.